US Patent 12102619 Methods of treating tuberous sclerosis complex with cannabidiol and everolimus

Is a

Patent

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

121026190

Patent Inventor Names

Geoffrey Guy0

Eduardo Dunayevich0

David Critchley0

Volker Knappertz0

Date of Patent

October 1, 2024

Patent Application Number

178411670

Date Filed

June 15, 2022

Patent Citations

‌

US Patent 11311498 Use of cannabinoids in the treatment of epilepsy

‌

US Patent 11633369 Use of cannabinoids in the treatment of epilepsy

‌

US Patent 11679087 Use of cannabinoids in the treatment of Angelman syndrome

‌

US Patent 11684598 Use of cannabinoids in the treatment of epilepsy

‌

US Patent 11701330 Use of cannabinoids in the treatment of epilepsy

‌

US Patent 11709671 Intelligent prefetching for OS components

‌

US Patent 11766411 Use of cannabinoids in the treatment of epilepsy

‌

US Patent 11865102 Cannabidiol preparations and its uses

...

Patent Primary Examiner

‌

Michael V Meller

Patent abstract

The present disclosure provides methods of treating tuberous sclerosis complex comprising administering cannabidiol and everolimus.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

US Patent 12102619 Methods of treating tuberous sclerosis complex with cannabidiol and everolimus

Contents

Patent attributes

Timeline

Further Resources

References

Find more entities like US Patent 12102619 Methods of treating tuberous sclerosis complex with cannabidiol and everolimus